Cobalt has advised the Latvian private healthcare group Repharm on the acquisition of a network of MediCA, Kardiolita, and 33 other clinics from UAB CGP Management, and their subsequent merger with InMedica, a network of medical clinics indirectly managed by the INVL Baltic Sea Growth Fund.
The transaction remains subject to regulatory approval.
INVL Baltic Sea Growth Fund is managed by Lithuania's INVL Asset Management, which controls 70% of UAB InMedica shares through UAB BSGF Sanus. InMedica is a network of primary health care institutions providing services in various cities of the country. The InMedica group currently consists of 22 clinics.
Cobalt’s team included Partner Elijus Burgis and Senior Associates Julija Aleska and Deimante Pagiriene.
Cobalt did not reply to our inquiry on the matter.
